ARCHIVES

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 24 | June 15, 1990

Download PDF Visit The Full Archive

Related Articles

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

Funds Earmarked From NCI Budget for Action Plan

October 24, 1996

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998